Rapid and durable recovery of immune effector cells in myelofibrosis patients treated with momelotinib.
Makker J., Thaw KH., Sheikh A., Cadman-Davies L., Duminuco A., Torre E., Panetta M., Stanley C., De Lavallade H., Curto-Garcia N., Sriskandarajah P., O'Sullivan J., Radia DH., Woodley C., Narciso B., Asirvatham S., Psaila B., Kordasti S., Harrison C., Harrington P.
Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK; GKT School of Medical Education, King's College London, London.